Hubert Catherine, Sempoux Christine, Rahier Jacques, Horsmans Yves, Geubel André, Van Beers Bernard E, Annet Laurence, Zech Francis, Leonard Daniel, Gigot Jean-François
Unit of Hepato-Biliary and Pancreatic Surgery, Department of Abdominal Surgery and Transplantation Saint-Luc University Hospital, Université Catholique de Louvain (UCL), Hippocrate Avenue, 10, Brussels, Belgium.
Hepatogastroenterology. 2007 Sep;54(78):1791-7.
BACKGROUND/AIMS: Surgical resection is a standard treatment of hepatocellular carcinoma, but liver cirrhosis is known to be associated to a high tumor recurrence rate.
A retrospective study of 55 consecutive patients (37 males, 18 females) suffering from hepatocellular carcinoma having undergone surgical resection. Hepatocellular carcinoma developed in 29 patients with normal liver (group A) and in 26 patients with chronic liver disease (CLD) (group B). Patients were significantly older and at high-risk in Group B.
Radical liver resection was achieved in 98% (100% in group A; 96% in group B). Overall 2-month mortality was 2% (0% in group A; 4% in group B). The 5-year overall and disease-free survival was respectively 55% and 35%. However, the 5-year overall and disease-free survival was significantly better in Group A (71% and 59%) compared to Group B (37% and 6%) (p < 0.001), respectively. Multivariate statistical analysis demonstrated that age > 50 years, poor tumor differentiation and presence of satellite nodules were significant independent adverse predictive factors of overall and disease-free survival.
Resection of HCC is safe and effective with satisfactory overall and disease-free survival rates, except when underlying chronic liver disease and poor tumor differentiation are present.
背景/目的:手术切除是肝细胞癌的标准治疗方法,但已知肝硬化与高肿瘤复发率相关。
对55例连续接受手术切除的肝细胞癌患者(37例男性,18例女性)进行回顾性研究。29例肝正常的患者(A组)和26例慢性肝病(CLD)患者(B组)发生了肝细胞癌。B组患者年龄明显更大且处于高风险状态。
98%的患者实现了根治性肝切除(A组为100%;B组为96%)。总体2个月死亡率为2%(A组为0%;B组为4%)。5年总生存率和无病生存率分别为55%和35%。然而,A组的5年总生存率和无病生存率(分别为71%和59%)明显优于B组(分别为37%和6%)(p < 0.001)。多变量统计分析表明,年龄>50岁、肿瘤分化差和存在卫星结节是总生存率和无病生存率的显著独立不良预测因素。
除存在潜在慢性肝病和肿瘤分化差的情况外,肝癌切除安全有效,总生存率和无病生存率令人满意。